Sign In
Last checked at 
30 May 2018 15:20
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Sigurdur Olafsson | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Hikma Pharmaceuticals PLC | ||||
b) | LEI | 549300BNS685UXH4JI75 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | ||||
b) | Nature of the transaction
| Market purchase of 20,000 Ordinary Shares by Landsbankinn for and on behalf of Sigurdur Olafsson. | ||||
c) | Price(s) and volume(s) | Price(s): £13.0919 Volume(s): 20,000 | ||||
d) | Aggregated information - Volume - Price |
£261,838.00 | ||||
e) | Date of the transaction | 30 May 2018 | ||||
f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760
Follow the stocks
